Chromatin Immunoprecipitation Sequencing: Clinical Trials

16 trials of Chromatin Immunoprecipitation Sequencing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 4 unknown, 3 completed, 1 not yet recruiting. 6 Not applicable, 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable6Recruiting 3, Completed 1, Terminated 1, Unknown 1
Phase 23Completed 1, Not yet recruiting 1, Recruiting 1
Phase 11Unknown 1
Phase 31Completed 1

Follow Chromatin Immunoprecipitation Sequencing: new trials by email Literature Review of Chromatin Immunoprecipitation Sequencing trials Research Report on Chromatin Immunoprecipitation Sequencing

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.
Immuno-PET - Locally Advanced or Metastatic Breast Cancer
Phase 2Not yet recruitingUNICANCER302026-12-312026-07-31
Pre-malignant States to Hematologic Malignancies in Firefighters
Monoclonal Gammopathy, Complete Blood Count with differential (CBC w/ diff), Clonal hematopoiesis (CHIP) - Clonal Hematopoiesis of Indeterminate Potential, Monoclonal Gammopathy
RecruitingWake Forest University Health Sciences3002026-06-232026-07-13
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Educational Intervention, Electronic Health Record Review, Follow-Up - Breast Carcinoma, Colorectal Carcinoma
Not applicableRecruitingUniversity of Michigan Rogel Cancer Center802026-01-092026-01-21
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Aerobic Exercise, Behavioral Intervention, Follow-Up - Cancer-related Cognitive Dysfunction, Primary Brain Neoplasm
Not applicableRecruitingEmory University602025-02-132026-01-09
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Biospecimen Collection, Bone Marrow Aspiration, Electronic Health Record Review - Lymphoproliferative Disorder, Multiple Myeloma
Not applicableRecruitingMayo Clinic822024-11-222026-10-01
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Follow-Up, Physical Examination, Questionnaire Administration - Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia
RecruitingOhio State University Comprehensive Cancer Center9602023-10-252026-06-12
Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial
Biospecimen Collection, Follow-Up - Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Not applicableCompletedM.D. Anderson Cancer Center12021-03-042025-02-26
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
Chest Radiography, Computed Tomography, Follow-Up - Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Phase 2RecruitingM.D. Anderson Cancer Center2272020-12-282026-09-14
Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment
ATAC-seq and ChIP-seq - Multiple Myeloma
UnknownRegina Elena Cancer Institute1502020-12-222023-05-15
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer
Computed Tomography, Electronic Health Record Review, Follow-Up - Anal Squamous Cell Carcinoma, Stage 0 Anal Cancer AJCC v8
CompletedM.D. Anderson Cancer Center412019-07-312024-02-20
Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma
ChIP-seq, NGS, ATAC-seq - Multiple Myeloma
UnknownRegina Elena Cancer Institute2002019-06-182024-03-22
The Vitality Project for Fatigued Female Cancer Survivors
Qigong, Healthy Living (CHIP + Pre-Train) - Fatigue, Cancer Survivorship
Not applicableUnknownThe Miriam Hospital752017-07-242017-08-23
Rituximab in Interstitial Pneumonitis
Rituximab, Zr-89-rituximab immuno PET/CT - Lung Diseases, Interstitial, Pneumonitis, Interstitial
Phase 2 / Phase 3CompletedHuman Adams202014-09-012018-05-31
Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)
Crosslinking, antibiotic treatment - Bacterial Keratitis, Fungal Keratitis
Not applicableTerminatedNantes University Hospital212014-09-012017-06-01
Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
Riboflavin 0.1% ophthalmic solution, CCL-VARIO UV lamp, CCL-VARIO at 18 mW/cm2 - Keratoconus, Corneal Ectasia
Phase 1UnknownRobert Mack, M.D.1002013-10-012015-12-14
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Follow-Up, Medical Chart Review - Cervical Large Cell Neuroendocrine Carcinoma, Cervical Neuroendocrine Carcinoma
RecruitingM.D. Anderson Cancer Center7502013-05-162026-09-14

Conditions studied

Multiple Myeloma (4)  ·  Breast Neoplasms (3)  ·  Anus Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Breast Carcinoma In Situ (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Colorectal Neoplasms (1)  ·  Dilatation, Pathologic (1)  ·  Fatigue (1)  ·  Inflammation (1)  ·  Keratoconus (1)  ·  Leukemia (1)  ·  Lung Diseases, Interstitial (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, Mantle-Cell (1)

Sponsors

M.D. Anderson Cancer Center (4)  ·  Regina Elena Cancer Institute (2)  ·  Emory University (1)  ·  Human Adams (1)  ·  Mayo Clinic (1)  ·  Nantes University Hospital (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Robert Mack, M.D. (1)  ·  The Miriam Hospital (1)  ·  UNICANCER (1)  ·  University of Michigan Rogel Cancer Center (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (11)  ·  Italy (2)  ·  France (1)  ·  Netherlands (1)

Top investigators

Barbara Pistilli, MD, PhD (1)  ·  Benny Johnson (1)  ·  Christina L Roland, MD (1)  ·  Ellen Flynn, MD (1)  ·  J C Grutters, MD, PhD (1)  ·  Jinbing Bai, PhD, RN (1)  ·  Larissa A. Meyer (1)  ·  Larry Druhan, PhD (1)  ·  Maurizio Fanciulli, PhD (1)  ·  Mithun V. Shah, MD (1)  ·  Robert J Mack, M.D. (1)  ·  Sagar D Sardesai, MSPH, PhD (1)  ·  Yang Gong (1)  ·  Yun Jiang (1)

Results publications

PMID 32557558, PMID 36826476, PMID 37204076

NIH funding

2025 (1), P30CA138292 (1)